SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Instagram Outage Disrupts Thousands of U.S. Users 
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals 
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility 
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices 
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals 
Juul, an American electronic cigarette company, will be ordered by the U.S. Food and Drug Administration (FDA) to remove its products from the local market. The said federal agency will soon ban the sale of the company’s sweet and fruity e-cigarette cartridges in the country.
According to Fox Business, the FDA is now preparing to hand over its order for Juul Labs Inc. to pull out its e-cigarette products from the U.S. market, and this was revealed by sources who are familiar with the matter.
It was reported that the agency may announce its decision as early as any time this week. The possible order of ban follows an almost two-year data review that was presented by Juul that was seeking permission to continue the sale of its tobacco and menthol-flavored products in the U.S.
Since the company started to be monitored by the FDA four years ago, Juul’s future fell into uncertainty. This was because its trendy marketing for its fruity vapes was blamed for the surge of underage vaping. Since then, the company has done its best to earn the trust of the public and regulators once again.
Juul limited its marketing campaign, and it stopped the sale of fruity and sweet flavors in 2019. However, the company’s sales have been declining in recent years.
At any rate, while Juul is close to being banned in the market, its rivals such as NJOY Holdings Inc. and Reynolds American Inc. managed to keep their similar products on the market. This was why business observers first thought that Juul would also get the same clearance.
With the imminent announcement of the ban from the FDA, it was said that Juul may pursue an appeal. The company may either challenge the agency’s decision in court or file a revised application for its product lines.
Meanwhile, Reuters reported that shares of Altria Group Inc. tobacco company, the parent of Juul, slid down by eight percent in morning trading following the reports of the FDA’s possible ban decision, which could be handed down this week.
